High circulating levels of S100A8/A9 complex (calprotectin) in male Japanese with abdominal adiposity and dysregulated expression of S100A8 and S100A9 in adipose tissues of obese mice

Biochemical and Biophysical Research Communications

Volumn 419, Issue 4, 2012, Pages 782-789

  Sekimoto, Ryohei ^a   Kishida, Ken ^a   Nakatsuji, Hideaki ^a   Nakagawa, Tohru ^b   Funahashi, Tohru ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

^b HITACHI LTD   (Japan)

Author keywords

Adiposity; Calprotectin; S100A8; S100A9

Indexed keywords

ADIPONECTIN; ADVANCED GLYCATION END PRODUCT RECEPTOR; CALGRANULIN; CALGRANULIN A; CALGRANULIN B; MESSENGER RNA; SERUM AMYLOID A; SERUM AMYLOID A 3 PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CONTROLLED STUDY; EPIDIDYMIS FAT; HUMAN; INTRAABDOMINAL FAT; JAPANESE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MESENTERIC FAT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STROMA CELL; SUBCUTANEOUS FAT;

3T3-L1 CELLS; ABDOMINAL FAT; ADIPOSE TISSUE; ADIPOSITY; ADULT; AGED; ANIMALS; ASIAN CONTINENTAL ANCESTRY GROUP; CALGRANULIN A; CALGRANULIN B; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; OBESITY;

MURINAE; MUS;

EID: 84858752110     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.102     Document Type: Article

References (24)

1. Ravasi T., Hsu K., Goyette J., et al. Probing the S100 protein family through genomic and functional analysis. Genomics 2004, 84:10-22.
2. Ehrchen J.M., Sunderkötter C., Foell D., et al. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J. Leukoc. Biol. 2009, 86:557-566.
3. Frosch M., Strey A., Vogl T., et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in paciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2000, 43:628-637.
4. Altwegg L.A., Neidhart M., Hersberger M., et al. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur. Heart J. 2007, 28:941-948.
5. Morrow D.A., Wang Y., Croce K., et al. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. Am. Heart J. 2008, 155:49-55.
6. Miyamoto S., Ueda M., Ikemoto M., et al. Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina. Heart 2008, 94:1002-1007.
7. Ionita M.G., Vink A., Dijke I.E., et al. High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1220-1227.
8. Katashima T., Naruko T., Terasaki F., et al. Enhanced expression of the S100A8/A9 complex in acute myocardial infarction patients. Circ. J. 2010, 74:741-748.
9. Zwadlo G., Brüggen J., Gerhards G., et al. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin. Exp. Immunol. 1988, 72:510-515.
10. Odink K., Cerletti N., Brüggen J., et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987, 330:80-82.
11. McCormick M.M., Rahimi F., Bobryshev Y.V., et al. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J. Biol. Chem. 2005, 280:41521-41529.
12. Croce K., Gao H., Wang Y., et al. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 2009, 120:427-436.
13. Lim S.Y., Raftery M.J., Goyette J., et al. Oxidative modifications of S100 proteins: functional regulation by redox. J. Leukoc. Biol. 2009, 86:577-587.
14. Vogl T., Tenbrock K., Ludwig S., et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 2007, 13:1042-1049.
15. Leclerc E., Fritz G., Vetter S.W., et al. Binding of S100 proteins to RAGE: an update. Biochim. Biophys. Acta 2009, 1793:993-1007.
16. Hiratsuka S., Watanabe A., Sakurai Y., et al. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol. 2008, 10:1349-1355.
17. Hiuge-Shimizu A., Maeda N., Hirata A., et al. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone. Arterioscler. Thromb. Vasc. Biol. 2011, 31:792-799.
18. Nakatsuji H., Kishida K., Funahashi T., et al. Three-month treatment with pioglitazone reduces circulating levels of S100A8/A9 (MRP8/14) complex, a biomarker of inflammation, without changes in body mass index, in type 2 diabetics with abdominal obesity. Diabetes Res. Clin. Pract. 2012, e58-e60.
19. Kishida K., Kuriyama H., Funahashi T., et al. Aquaporin adipose, a putative glycerol channel in adipocytes. J. Biol. Chem. 2000, 275:20896-20902.
20. Mortensen O.H., Nielsen A.R., Erikstrup C., et al. Calprotectin-a novel marker of obesity. PLoS ONE 2009, 4:e7419.
21. Catalán V., Gómez-Ambrosi J., Rodríguez A., et al. Increased levels of calprotectin in obesity are related to macrophage content. Impact on inflammation and effect of weight loss. Mol. Med. 2011, 10.2119/molmed.2011.00144.
22. Suganami T., Mieda T., Ogawa Y., et al. Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem. Biophys. Res. Commun. 2007, 354:45-49.
23. Tsukumo D.M., Carvalho-Filho M.A., Saad M.J., et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007, 56:1986-1998.
24. Averill M.M., Barnhart S., Becker L., et al. S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation. Circulation 2011, 123:1216-1226.